 | • レポートコード：GIR-107A12622 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、前立腺がん治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。前立腺がん治療の種類別市場規模（生物学的療法、化学療法）、用途別市場規模（病院、研究機関、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・前立腺がん治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Tolmar、Astellas Pharma、AstraZeneca、Ferring Pharmaceuticals、Johnson & Johnson、Abbott、Sanofi、Ipsen、Novartis、Bayer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：生物学的療法、化学療法 ・用途別分析2016年-2026年：病院、研究機関、クリニック ・前立腺がん治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・前立腺がん治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・前立腺がん治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・前立腺がん治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・前立腺がん治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Prostate Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Prostate Cancer Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Prostate Cancer Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Prostate Cancer Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biological Therapy
Chemotherapy
Market segment by Application, can be divided into
Hospital
Research Institution
Clinic
Market segment by players, this report covers
Tolmar
Astellas Pharma
AstraZeneca
Ferring Pharmaceuticals
Johnson & Johnson
Abbott
Sanofi
Ipsen
Novartis
Bayer
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prostate Cancer Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prostate Cancer Treatment, with revenue, gross margin and global market share of Prostate Cancer Treatment from 2019 to 2021.
Chapter 3, the Prostate Cancer Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Prostate Cancer Treatment market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Prostate Cancer Treatment research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Prostate Cancer Treatment
1.2 Classification of Prostate Cancer Treatment by Type
1.2.1 Overview: Global Prostate Cancer Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prostate Cancer Treatment Revenue Market Share by Type in 2020
1.2.3 Biological Therapy
1.2.4 Chemotherapy
1.3 Global Prostate Cancer Treatment Market by Application
1.3.1 Overview: Global Prostate Cancer Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Research Institution
1.3.4 Clinic
1.4 Global Prostate Cancer Treatment Market Size & Forecast
1.5 Global Prostate Cancer Treatment Market Size and Forecast by Region
1.5.1 Global Prostate Cancer Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prostate Cancer Treatment Market Size by Region, (2016-2021)
1.5.3 North America Prostate Cancer Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Prostate Cancer Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prostate Cancer Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Prostate Cancer Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prostate Cancer Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostate Cancer Treatment Market Drivers
1.6.2 Prostate Cancer Treatment Market Restraints
1.6.3 Prostate Cancer Treatment Trends Analysis
2 Company Profiles
2.1 Tolmar
2.1.1 Tolmar Details
2.1.2 Tolmar Major Business
2.1.3 Tolmar Prostate Cancer Treatment Product and Solutions
2.1.4 Tolmar Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Tolmar Recent Developments and Future Plans
2.2 Astellas Pharma
2.2.1 Astellas Pharma Details
2.2.2 Astellas Pharma Major Business
2.2.3 Astellas Pharma Prostate Cancer Treatment Product and Solutions
2.2.4 Astellas Pharma Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Astellas Pharma Recent Developments and Future Plans
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Prostate Cancer Treatment Product and Solutions
2.3.4 AstraZeneca Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 AstraZeneca Recent Developments and Future Plans
2.4 Ferring Pharmaceuticals
2.4.1 Ferring Pharmaceuticals Details
2.4.2 Ferring Pharmaceuticals Major Business
2.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Product and Solutions
2.4.4 Ferring Pharmaceuticals Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Ferring Pharmaceuticals Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Prostate Cancer Treatment Product and Solutions
2.5.4 Johnson & Johnson Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Prostate Cancer Treatment Product and Solutions
2.6.4 Abbott Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Abbott Recent Developments and Future Plans
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Prostate Cancer Treatment Product and Solutions
2.7.4 Sanofi Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Sanofi Recent Developments and Future Plans
2.8 Ipsen
2.8.1 Ipsen Details
2.8.2 Ipsen Major Business
2.8.3 Ipsen Prostate Cancer Treatment Product and Solutions
2.8.4 Ipsen Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Ipsen Recent Developments and Future Plans
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Prostate Cancer Treatment Product and Solutions
2.9.4 Novartis Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Novartis Recent Developments and Future Plans
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business
2.10.3 Bayer Prostate Cancer Treatment Product and Solutions
2.10.4 Bayer Prostate Cancer Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bayer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prostate Cancer Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Prostate Cancer Treatment Players Market Share
3.2.2 Top 10 Prostate Cancer Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Prostate Cancer Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prostate Cancer Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Prostate Cancer Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prostate Cancer Treatment Revenue Market Share by Application (2016-2021)
5.2 Prostate Cancer Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prostate Cancer Treatment Revenue by Type (2016-2026)
6.2 North America Prostate Cancer Treatment Revenue by Application (2016-2026)
6.3 North America Prostate Cancer Treatment Market Size by Country
6.3.1 North America Prostate Cancer Treatment Revenue by Country (2016-2026)
6.3.2 United States Prostate Cancer Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Prostate Cancer Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Prostate Cancer Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prostate Cancer Treatment Revenue by Type (2016-2026)
7.2 Europe Prostate Cancer Treatment Revenue by Application (2016-2026)
7.3 Europe Prostate Cancer Treatment Market Size by Country
7.3.1 Europe Prostate Cancer Treatment Revenue by Country (2016-2026)
7.3.2 Germany Prostate Cancer Treatment Market Size and Forecast (2016-2026)
7.3.3 France Prostate Cancer Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prostate Cancer Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Prostate Cancer Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Prostate Cancer Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prostate Cancer Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Prostate Cancer Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Prostate Cancer Treatment Market Size by Region
8.3.1 Asia-Pacific Prostate Cancer Treatment Revenue by Region (2016-2026)
8.3.2 China Prostate Cancer Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Prostate Cancer Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Prostate Cancer Treatment Market Size and Forecast (2016-2026)
8.3.5 India Prostate Cancer Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prostate Cancer Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Prostate Cancer Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prostate Cancer Treatment Revenue by Type (2016-2026)
9.2 South America Prostate Cancer Treatment Revenue by Application (2016-2026)
9.3 South America Prostate Cancer Treatment Market Size by Country
9.3.1 South America Prostate Cancer Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Prostate Cancer Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Prostate Cancer Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prostate Cancer Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Prostate Cancer Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Prostate Cancer Treatment Market Size by Country
10.3.1 Middle East & Africa Prostate Cancer Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Prostate Cancer Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prostate Cancer Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Prostate Cancer Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Prostate Cancer Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prostate Cancer Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prostate Cancer Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prostate Cancer Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prostate Cancer Treatment Revenue Market Share by Region (2021-2026)
Table 6. Tolmar Corporate Information, Head Office, and Major Competitors
Table 7. Tolmar Major Business
Table 8. Tolmar Prostate Cancer Treatment Product and Solutions
Table 9. Tolmar Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 11. Astellas Pharma Major Business
Table 12. Astellas Pharma Prostate Cancer Treatment Product and Solutions
Table 13. Astellas Pharma Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 15. AstraZeneca Major Business
Table 16. AstraZeneca Prostate Cancer Treatment Product and Solutions
Table 17. AstraZeneca Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Ferring Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Ferring Pharmaceuticals Major Business
Table 20. Ferring Pharmaceuticals Prostate Cancer Treatment Product and Solutions
Table 21. Ferring Pharmaceuticals Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 23. Johnson & Johnson Major Business
Table 24. Johnson & Johnson Prostate Cancer Treatment Product and Solutions
Table 25. Johnson & Johnson Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Abbott Corporate Information, Head Office, and Major Competitors
Table 27. Abbott Major Business
Table 28. Abbott Prostate Cancer Treatment Product and Solutions
Table 29. Abbott Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Sanofi Corporate Information, Head Office, and Major Competitors
Table 31. Sanofi Major Business
Table 32. Sanofi Prostate Cancer Treatment Product and Solutions
Table 33. Sanofi Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Ipsen Corporate Information, Head Office, and Major Competitors
Table 35. Ipsen Major Business
Table 36. Ipsen Prostate Cancer Treatment Product and Solutions
Table 37. Ipsen Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Novartis Corporate Information, Head Office, and Major Competitors
Table 39. Novartis Major Business
Table 40. Novartis Prostate Cancer Treatment Product and Solutions
Table 41. Novartis Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bayer Corporate Information, Head Office, and Major Competitors
Table 43. Bayer Major Business
Table 44. Bayer Prostate Cancer Treatment Product and Solutions
Table 45. Bayer Prostate Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Prostate Cancer Treatment Revenue (USD Million) by Players (2019-2021)
Table 47. Global Prostate Cancer Treatment Revenue Share by Players (2019-2021)
Table 48. Breakdown of Prostate Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Prostate Cancer Treatment Players Head Office, Products and Services Provided
Table 50. Prostate Cancer Treatment Mergers & Acquisitions in the Past Five Years
Table 51. Prostate Cancer Treatment New Entrants and Expansion Plans
Table 52. Global Prostate Cancer Treatment Revenue (USD Million) by Type (2016-2021)
Table 53. Global Prostate Cancer Treatment Revenue Share by Type (2016-2021)
Table 54. Global Prostate Cancer Treatment Revenue Forecast by Type (2021-2026)
Table 55. Global Prostate Cancer Treatment Revenue by Application (2016-2021)
Table 56. Global Prostate Cancer Treatment Revenue Forecast by Application (2021-2026)
Table 57. North America Prostate Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Prostate Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Prostate Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Prostate Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Prostate Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Prostate Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Prostate Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Prostate Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Prostate Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Prostate Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Prostate Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Prostate Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Prostate Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Prostate Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Prostate Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Prostate Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Prostate Cancer Treatment Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Prostate Cancer Treatment Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Prostate Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Prostate Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Prostate Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Prostate Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Prostate Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Prostate Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Prostate Cancer Treatment Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Prostate Cancer Treatment Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Prostate Cancer Treatment Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Prostate Cancer Treatment Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Prostate Cancer Treatment Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Prostate Cancer Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prostate Cancer Treatment Picture
Figure 2. Global Prostate Cancer Treatment Revenue Market Share by Type in 2020
Figure 3. Biological Therapy
Figure 4. Chemotherapy
Figure 5. Prostate Cancer Treatment Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Research Institution Picture
Figure 8. Clinic Picture
Figure 9. Global Prostate Cancer Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Prostate Cancer Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Prostate Cancer Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global Prostate Cancer Treatment Revenue Market Share by Region in 2020
Figure 13. North America Prostate Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Prostate Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Prostate Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Prostate Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Prostate Cancer Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Prostate Cancer Treatment Market Drivers
Figure 19. Prostate Cancer Treatment Market Restraints
Figure 20. Prostate Cancer Treatment Market Trends
Figure 21. Tolmar Recent Developments and Future Plans
Figure 22. Astellas Pharma Recent Developments and Future Plans
Figure 23. AstraZeneca Recent Developments and Future Plans
Figure 24. Ferring Pharmaceuticals Recent Developments and Future Plans
Figure 25. Johnson & Johnson Recent Developments and Future Plans
Figure 26. Abbott Recent Developments and Future Plans
Figure 27. Sanofi Recent Developments and Future Plans
Figure 28. Ipsen Recent Developments and Future Plans
Figure 29. Novartis Recent Developments and Future Plans
Figure 30. Bayer Recent Developments and Future Plans
Figure 31. Global Prostate Cancer Treatment Revenue Share by Players in 2020
Figure 32. Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Prostate Cancer Treatment Revenue Market Share in 2020
Figure 34. Global Top 10 Players Prostate Cancer Treatment Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Prostate Cancer Treatment Revenue Share by Type in 2020
Figure 37. Global Prostate Cancer Treatment Market Share Forecast by Type (2021-2026)
Figure 38. Global Prostate Cancer Treatment Revenue Share by Application in 2020
Figure 39. Global Prostate Cancer Treatment Market Share Forecast by Application (2021-2026)
Figure 40. North America Prostate Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 41. North America Prostate Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 42. North America Prostate Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 43. United States Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Prostate Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 47. Europe Prostate Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 48. Europe Prostate Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 49. Germany Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Prostate Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Prostate Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Prostate Cancer Treatment Revenue Market Share by Region (2016-2026)
Figure 57. China Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Prostate Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 64. South America Prostate Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 65. South America Prostate Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Prostate Cancer Treatment Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Prostate Cancer Treatment Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Prostate Cancer Treatment Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Prostate Cancer Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の前立腺がん市場 2021：企業別、地域別、種類・用途別 The Prostate Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…- 前立腺がん市場：世界及び中国市場分析・予測（～2024年） Prostate Cancer Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Prostate Cancer industry with a focus on the Chinese market. The report provides key statistics on the market status of the Prostate Cancer manufacturers and is a…
- ホルモン抵抗性前立腺がん（HRPCA）市場：世界及び中国市場分析・予測（～2024年） Hormone Refractory Prostate Cancer (HRPCA) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Hormone Refractory Prostate Cancer (HRPCA) industry with a focus on the Chinese market. The report provides key statistics on the marke…
- 世界の上皮性卵巣がん治療市場 2021：企業別、地域別、種類・用途別 The Epithelial Ovarian Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の男性乳がん治療市場 2021：企業別、地域別、種類・用途別 The Male Breast Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…